Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been somewhat neglected. It nevertheless represents a major health problem in these patients, and is...
-
April 13, 2018 (v1)Journal articleEarly postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasiaUploaded on: March 10, 2024
-
September 18, 2013 (v1)Journal article
Achondroplasia is a rare genetic disease characterized by abnormal bone development, resulting in short stature. It is caused by a single point mutation in the gene coding for fibroblast growth factor receptor 3 (FGFR3), which leads to prolonged activation upon ligand binding. To prevent excessive intracellular signaling and rescue the symptoms...
Uploaded on: October 11, 2023 -
September 18, 2013 (v1)Journal article
Achondroplasia is a rare genetic disease characterized by abnormal bone development, resulting in short stature. It is caused by a single point mutation in the gene coding for fibroblast growth factor receptor 3 (FGFR3), which leads to prolonged activation upon ligand binding. To prevent excessive intracellular signaling and rescue the symptoms...
Uploaded on: December 3, 2022 -
September 18, 2013 (v1)Journal article
A recombinant soluble fibroblast growth factor receptor 3 (FGFR3) restored normal skeletal growth and prevented disease-related complications in a mouse model of achondroplasia.
Uploaded on: March 10, 2024